Legal Medicine
Volume 11, Issue 6 , Pages 298-301 , November 2009

Diplotype analysis of the human cardiac sodium channel regulatory region in Japanese cases of sudden death by unknown causes

  • Masato Nakatome

      Affiliations

    • Department of Legal Medicine, Fujita Health University School of Medicine, Aichi 470-1192, Japan
    • Corresponding Author InformationCorresponding author. Tel.: +81 562 93 2438; fax: +81 562 92 4580.
    • ,
  • Takuma Yamamoto

      Affiliations

    • Legal Medicine, Department of Social and Environmental Medicine, Osaka University Graduate School of Medicine, Osaka 565-0871, Japan
    • ,
  • Ichiro Isobe

      Affiliations

    • Department of Legal Medicine, Fujita Health University School of Medicine, Aichi 470-1192, Japan
    • ,
  • Ryoji Matoba

      Affiliations

    • Legal Medicine, Department of Social and Environmental Medicine, Osaka University Graduate School of Medicine, Osaka 565-0871, Japan

Received 2 June 2009 ,Revised 21 August 2009 ,Accepted 21 August 2009.

References 

  1. Goldin AL, Barchi RL, Caldwell JH, et al. Nomenclature of voltage-gated sodium channels. Neuron. 2000;28:365–368
  2. Viswanathan PC, Benson DW, Balser JR. A common SCN5A polymorphism modulates the biophysical effects of an SCN5A mutation. J Clin Invest. 2003;111:341–346
  3. Morentin B, Suárez-Mier MP, Aguilera B. Sudden unexpected death among persons 1–35 years old. Forensic Sci Int. 2003;135(3):213–217
  4. Schwarz PJ, Periti M, Malliani A. The long QT syndrome. Am Heart J. 1975;89:378–390
  5. Moss AJ, Schwarz PJ, Crampton RS, et al. The long QT syndrome: prospective longitudinal study of 328 families. Circulation. 1991;84:1136–1144
  6. Horie M, Itoh H. Disorders of cardiac repolarization – Long QT and short QT syndrome. Circ J. 2007;Suppl A:A-50–A-53
  7. Brugada J, Brugada R, Brugada P. Right bundle-branch block and ST-segment elevation in leadsV1 through V3: a marker for sudden death in patients without demonstrable structural heart disease. Circulation. 1998;97:457–460
  8. Clancy CE, Wehrens XHT. Mutation-specific effects of lidocaine in Brugada syndrome. Int J Cardiol. 2007;121(3):249–252
  9. Dumaine R, Towbin JA, Brugada P, et al. Ionic mechanisms responsible for the electrocardiographic phenotype of the Brugada syndrome are temperature dependent. Circ Res. 1999;85:803–809
  10. Wang DW, Makita N, Kitabatake A, et al. Enhanced Na+ channel intermediate inactivation in Brugada syndrome. Circ Res. 2000;87:e37–e43
  11. Meregalli PG, Tan HL, Probst V, et al. Type of SCN5A mutation determines clinical severity and degree of conduction slowing in loss-of-function sodium channelopathies. Heart Rhythm. 2009;6(3):341–348
  12. Morita H, Nagase S, Miura D, et al. Differential effects of cardiac sodium channel mutations on initiation of ventricular arrhythmias in patients with Brugada syndrome. Heart Rhythm. 2009;6(4):487–489
  13. Otagiri T, Kijima K, Osawa M, et al. Cardiac ion channel gene mutations in sudden infant death syndrome. Pediatr Res. 2008;64:482–487
  14. Ackerman MJ, Sui BL, Sturner WQ, et al. Postmortem molecular analysis of SCN5A defects in sudden infant death syndrome. JAMA. 2001;286:2264–2269
  15. Arnestad M, Crotti L, Rognum TO, et al. Prevalent of long-QT syndrome gene variants in sudden infant death syndrome. Circulation. 2007;115:361–367
  16. Schott JJ, Alshinawi C, Kyndt F, et al. Cardiac conduction defects associate with mutations in SCN5A. Nat Genet. 1999;23(1):20–21
  17. Moric E, Herbert E, Trusz-Gluza M, et al. The implications of genetic mutations in the sodium channel gene (SCN5A). Europace. 2003;5:325–334
  18. Zang Z-S, Tranquillo J, Neplioueva V, et al. Sodium channel kinetic changes that produce Brugada syndrome or progressive cardiac conduction system disease. Am J Physiol Heart Circ Physiol. 2007;292:H399–H407
  19. Tan HL, Bezzina CR, Smits JPP, et al. Genetic control of sodium channel function. Cardiovasc Res. 2003;57:961–973
  20. Yang P, Koopmann TT, Pfeufer A, et al. Polymorphisms in the cardiac sodium channel promoter displaying variant in vitro expression activity. Eur J Hum Genet. 2008;16:350–357
  21. Baroudi G, Pouliot V, Denjoy I, et al. Novel mechanism for Brugada syndrome: defective surface locarization of an SCN5A mutant (R1432G). Circ Res. 2001;88:e78–e83
  22. Roden DM. Human genomics and its impact on arrhythmia. Trends Cardiovasc Med. 2004;14(3):112–116
  23. Yang P, Kupershmidt S, Roden DM. Cloning and initial characterization of the human cardiac sodium channel (SCN5A) promoter. Cardiovasc Res. 2004;61:56–65
  24. Bezzina CR, Shimizu W, Yang P, et al. Common sodium channel promoter haplotype in Asian subjects underlies variability in cardiac conduction. Circulation. 2006;113:338–344
  25. Klintschar M, Stiller D, Schwaiger P, et al. DNA polymorphisms in the tyrosine hydroxylase and GNB3 genes: association with unexpected death from acute myocardial infarction and increased heart weight. Forensic Sci Int. 2005;153(2):142–146
  26. Zhu BL, Tanaka S, Ishikawa T, et al. Forensic pathological investigation of myocardial hypoxia-inducible factor-1α, erythropoietin and vascular endothelial growth factor in cardiac death. Leg Med. 2008;10:11–19
  27. Nishio H, Iwata M, Tamura A, et al. Identification of a novel mutation V2321M of the cardiac ryanodine receptor gene of sudden unexplained death and a phenotypic study of the gene mutations. Leg Med. 2008;10:201–203
  28. Takahashi S, Kanetake J, Moriya T, et al. Sudden infant death from dilated cardiomyopathy with endocardial fibroelastosis. Leg Med. 2008;10:277–280
  29. Nishio H, Sato T, Fukunishi S, et al. Identification of malignant hyperthermia-susceptible ryanodine receptor type 1 gene (RYR1) mutations in a child who died in a car after exposure to a high environmental temperature. Leg Med. 2009;11:142–143
  30. Pine SR, Mechanic LE, Ambs S, et al. Lung cancer survival and functional polymorphisms in MBL2, an innate-immunity gene. J Natl Cancer Inst. 2007;99:1401–1409
  31. Morgan TR, Lambrecht RW, Bonkovsky HL, et al. DNA polymorphisms and response to treatment in patients with chronic hepatitis C: results from the HALT-C trial. J Hepatol. 2008;49:548–556

PII: S1344-6223(09)00323-X

doi: 10.1016/j.legalmed.2009.08.003

Legal Medicine
Volume 11, Issue 6 , Pages 298-301 , November 2009

Article Tools

* Image Usage & Resolution